Dr. John Mandrola shares a great update on the latest info regarding dabigatran (Pradaxa, Pradax). Dr. Mandrola not only treats atrial fibrillation patients, but he has also experienced afib himself. I have become an AF-doctor. That means my most exciting aspect of medicine is terminating AF with watts delivered through a catheter. “Got it.” In …
Read More
Our good friends at the Atrial Fibrillation Association (in the UK) have just sent out the message below. Please help them win funds to continue raising awareness of atrial fibrillation. Atrial Fibrillation Association (AFA) is calling on people to vote to help it secure funds for its vital projects to improve the lives of people …
Read More
In this video interview at Boston Atrial Fibrillation Symposium, Dr. Pierre Jais, of the University of Bordeaux (Bordeaux, France), clarifies his group's recently-published long-term catheter ablation results. These results were called "sobering" in the media, but Dr. Jais sees them as encouraging. Pierre Jais, MD, is Professor of Cardiology at …
Read More
In this video interview, Dr. Keith Ferdinand, Professor at Emory University and Chief Science Officer of the Association of Black Cardiologists, talked about minority health. He focused especially on heart disease and atrial fibrillation among blacks and African Americans. He addressed the conundrum of why blacks appear to have less …
Read More
In this video, Dr. Keith Ferdinand, Chief Science Officer of the Association of Black Cardiologists, talked about heart disease and atrial fibrillation among minorities, especially blacks and African Americans. He talked about why blacks appear to have less afib than whites, and what blacks should be doing to prevent AF and heart disease. Watch the …
Read More
In this video, Dr. Matthew Reynolds, of the Harvard Clinical Research Institute, discussed his quality of life findings from use of catheter ablation and antiarrhythmic drugs for treatment of atrial fibrillation. He analyzed quality of life data that was collected as part of the THERMOCOOL catheter trial in which catheter ablation was found to be …
Read More
StopAfib.org founder Mellanie True Hills with daytime TV star Susan Lucci and her husband Helmut Huber announcing Facing AFib partnership StopAfib.org is proud to participate in the Facing AFib program, which features daytime TV star Susan Lucci and her husband Helmut Huber. More than a decade ago, Huber was diagnosed with afib. Lucci and Huber …
Read More
Daytime TV star Susan Lucci and husband Helmut Huber discuss living with atrial fibrillation with StopAfib.org founder Mellanie True Hills in a new video released as part of the Facing AFib™ program to encourage getting serious about atrial fibrillation and stroke.
Read More
On the heels of the US FDA approving dabigatran, the long-awaited alternative to Coumadin (warfarin), comes word that Health Canada has as well. In Canada, dabigatran is known as PRADAX™. Because this is the first alternative to warfarin in Canada, it is big news for the afib community there. Learn more at: Health Canada Approves …
Read More
The long-awaited alternative to Coumadin (warfarin) has just been approved by the US FDA. The FDA just approved Pradaxa (dabigatran) for use by those with atrial fibrillation for preventing afib-related strokes. The FDA based approval on results of the RE-LY trial, which saw patients on Pradaxa having fewer strokes than those on warfarin. And Pradaxa …
Read More